POLYMORPHISM OF EXCISION REPAIR GENES XPD, XRCC1, hOGG1 IN THE POPULATION OF THE REPUBLIC OF BELARUS AND ITS IMPACT ON CARCINOGENESIS

Cover Page

Cite item

Full Text

Abstract

Background. DNA damage and induced mutational events are known to contribute notably to carcinogenesis, so the study of excision repair gene polymorphisms and their association with cancer risk is of great interest and importance. Materials and Methods. Excision repair gene polymorphisms (XRCC1 Arg399Gln, hOGG1 Ser326Cys, XPD Asp312Asn) were analyzed using a PCR-RFLP method in the group of bladder cancer (BC) patients compared to clinically healthy individuals. Results. In the healthy population, the frequencies of the minor alleles of XPD 312, XRCC1 399, hOGG1 326 genes were 42,1 %, 35,4 % and 24,4 %, respectively, i. e., in the range of values observed in Caucasian populations. The frequencies of genotypes/alleles in the group of BC patients did not differ from those in the control group. However, the frequency of Asn allele of XPD gene was significantly higher in men with BC recurrences as compared to primary tumors. The cancer risk was decreased in carriers of combined Asp/Asp, Arg/Arg, Ser/Ser genotypes of XPD, XRCC1 and hOGG1 genes (OR95 %CI = 0,46 [0,23 - 0,91] p = 0,024 and OR95 %CI = 0,42 [0,18 - 0,98] p = 0,045 for combination of two and three genes, respectively). Conclusion. In Belarus, the frequencies of the XPD, XRCC1 and hOGG1 minor alleles are similar to those in Caucasian populations. Although single nucleotide polymorphisms investigated did not affect the risk of bladder cancer, the risk of cancer recurrence was increased in carriers of the XPD Asn allele. Combined homozygous wild type alleles of indicated excision repair genes appeared to possess a protective effect against carcinogenesis.

About the authors

Volha Petrovna Ramaniuk

Institute of Genetics and Cytology, National Academy of Sciences of Belarus

Email: V.Ramaniuk@igc.bas-net.by
Junior Researcher. Laboratory of Genetic Safety

Natalya Vasilyevna Nikitchenko

Institute of Genetics and Cytology, National Academy of Sciences of Belarus

Email: N.Nikitchenko@igc.bas-net.by
Researcher. Laboratory of Genetic Safety

Natalya Viktorovna Savina

Institute of Genetics and Cytology, National Academy of Sciences of Belarus

Email: N.Savina@igc.bas-net.by
Researcher. Laboratory of Genetic Safety

Tatyana Danovna Kuzhir

Institute of Genetics and Cytology, National Academy of Sciences of Belarus

Email: T.Kuzhir@igc.bas-net.by
Leading Researcher, Dr. Sci. Laboratory of Genetic Safety

Roza Iosifovna Goncharova

Institute of Genetics and Cytology, National Academy of Sciences of Belarus

Email: R.Goncharova@igc.bas-net.by
Head of the laboratory, Dr. Sci., Professor. Laboratory of Genetic Safety

References

  1. Бабич П. Н., Чубенко А. В., Лапач С. Н. (2005) Применение современных статистических методов в практике клинических исследований. Сообщение третье. Отношение шансов: понятие, вычисление и интерпретация. Украïнський медичний часопис. № 2(46): С. 113-119.
  2. Белев Н. Ф. (2004) Роль генетических факторов в этиопатогенезе рака толстой кишки. Материалы III съезда онкологов и радиологов СНГ. Минск, 25-28 мая, 2004. Часть I: С. 64-68.
  3. Глобальный опрос взрослого населения о потреблении табака (GATS). Российская Федерация, 2009. Страновой отчет. 171 с. URL: http://www.who.int/tobacco/ru_tfi_gatsrussian_countryreport.pdf (дата обращения: 13.05.2013).
  4. Кужир Т. Д. (2009) Репарация ДНК при патологии: синдромы хромосомной нестабильности. Весцi НАН Беларусi, Сер. мед. навук. № 2: С. 96-102.
  5. Поляков С. М., Левин Л. Ф., Шебеко Н. Г., Щербина О. Ф. (2011) Злокачественные новообразования в Беларуси, 2001-2010 / под ред. М. М. Сачек, О. Г. Суконко, Минск: РНПЦ МТ. 205 с.
  6. Andrew A. S., Karagas M. R., Nelson H. H., et al. (2008) DNA repair polymorphisms modify bladder cancer risk: a multi-factor analytic strategy. Hum. Hered. V. 65: P. 105-118.
  7. Arizono K., Osada Y., Kuroda Y. (2008) DNA repair gene hOGG1 codon 326 and XRCC1 codon 399 polymorphisms and bladder cancer risk in a Japanese population. Jpn. J. Clin. Oncol. V. 38: P. 186-191.
  8. Bau D. T., Wu H. C., Chiu C. F., et al. (2007) Association of XPD polymorphisms with prostate cancer in Taiwanese patients. Anticancer Res. V. 27. P. 2893-2896.
  9. Berquist B. R., Singh D. K., Fan J., et al. (2010) Functional capacity of XRCC1 protein variants identified in DNA repair-deficient Chinese hamster ovary cell lines and the human population. Nucleic. Acids Res. V. 38: P. 5023-5035.
  10. Best B. P. (2009) Nuclear DNA damage as a direct cause of aging. Rejuvenation Res. V. 12: P. 199-208.
  11. Bonita R., Beaglehole R., Kjellström T. (2006) Basic Epidemiology. 2nd Edition. World Health Organization. 212 p.
  12. Brem R., Hall J. (2005) XRCC1 is required for DNA single-strand break repair in human cells. Nucleic Acids Res. V. 33: P. 2512-2520.
  13. Caldecott K. W., Aoufouchi S., Johnson P., Shall S. (1996) XRCC1 polypeptide interacts with DNA polymerase beta and possibly poly (ADP-ribose) polymerase, and DNA ligase III is a novel molecular 'nick-sensor' in vitro. Nucleic Acids Res. V. 24: P. 4387-4394.
  14. Capellá G., Pera G., Sala N., et al. (2008) DNA repair polymorphisms and the risk of stomach adenocarcinoma and severe chronic gastritis in the EPIC-EURGAST study. Int. J. Epidemiol. V. 37: P. 1316-1325.
  15. Chang C. H., Hsiao C. F., Chang G. C., et al. (2009 a) Interactive effect of cigarette smoking with human 8-oxoguanine DNA N-glycosylase 1 (hOGG1) polymorphisms on the risk of lung cancer: a case-control study in Taiwan. Am. J. Epidemiol. V. 170: P. 695-702.
  16. Chang J. S., Wrensch M. R., Hansen H. M., et al. (2009 b) Base excision repair genes and risk of lung cancer among San Francisco Bay Area Latinos and African-Americans. Carcinogenesis. V. 30: P. 78-87.
  17. Chen L., Elahi A., Pow-Sang J., et al. (2003) Association between polymorphism of human oxoguanine glycosylase 1 and risk of prostate cancer. J. Urol. V. 170: P. 2471-2474.
  18. Chen M., Kamat A. M., Huang M., et al. (2007) High-order interactions among genetic polymorphisms in nucleotide excision repair pathway genes and smoking in modulating bladder cancer risk. Carcinogenesis. V. 28: P. 2160-2165.
  19. Cho E. Y., Hildesheim A., Chen C. J., et al. (2003) Nasopharyngeal carcinoma and genetic polymorphisms of DNA repair enzymes XRCC1 and hOGG1. Cancer Epidemiol. Biomarkers Prev. V. 12: P. 1100-1104.
  20. David-Beabes G. L., London S. J. (2001) Genetic polymorphism of XRCC1 and lung cancer risk among African-Americans and Caucasians. Lung Cancer. V. 34: P. 333-339.
  21. De Ruyck K., Szaumkessel M., De Rudder I., et al. (2007) Polymorphisms in base-excision repair and nucleotide-excision repair genes in relation to lung cancer risk. Mutat. Res. V. 631: P. 101-110.
  22. Debniak T., Scott R. J., Huzarski T., et al. (2006) XPD common variants and their association with melanoma and breast cancer risk. Breast Cancer Res. Treat. V. 98: P. 209-215.
  23. Della-Maria J., Hegde M. L., McNeill D. R., et al. (2012) The interaction between polynucleotide kinase phosphatase and the DNA repair protein XRCC1 is critical for repair of DNA alkylation damage and stable association at DNA damage sites. J. Biol. Chem. V. 287: P. 39 233-39 244.
  24. Duell E. J., Holly E. A., Bracci P. M., et al. (2002) A population-based study of the Arg 399Gln polymorphism in X-ray repair cross-complementing group 1 (XRCC1) and risk of pancreatic adenocarcinoma. Cancer Res. V. 62: P. 4630-4636.
  25. Falagan-Lotsch P., Rodrigues M. S., Esteves V., et al. (2009) XRCC1 gene polymorphisms in a population sample and in women with a family history of breast cancer from Rio de Janeiro (Brazil). Genet. Mol. Biol. V. 32: P. 255-259.
  26. Figueiredo J. C., Knight J. A., Briollais L., et al. (2004)Polymorphisms XRCC1-R399Q and XRCC3-T241M and the risk of breast cancer at the Ontario site of the Breast Cancer Family Registry. Cancer Epidemiol. Biomarkers Prev. V. 13: P. 583-591.
  27. Figueroa J. D., Malats N., Real F. X., et al. (2007) Genetic variation in the base excision repair pathway and bladder cancer risk. Hum. Genetics. V. 121: P. 233-242.
  28. Försti A., Angelini S., Festa F., et al. (2004) Single nucleotide polymorphisms in breast cancer. Oncol. Rep. V. 11: P. 917-922.
  29. Franekova M., Halasova E., Bukovska E., et al. (2008) Gene polymorphisms in bladder cancer. Urol. Oncol. V. 26: P. 1-8.
  30. García-Closas M., Malats N., Real F. X., et al. (2006) Genetic variation in the nucleotide excision repair pathway and bladder cancer risk. Cancer Epidemiol. Biomarkers Prev. V. 15: P. 536-542.
  31. Goode E. L., Ulrich C. M., Potter J. D. (2002) Polymorphisms in DNA repair genes and association with cancer risk. Cancer Epidemiol. Biomarkers Prev. V. 11: P. 1513-1530.
  32. Guan P., Huang D., Yin Z., Zhou B. (2011) Association of the hOGG1 Ser326Cys polymorphism with increased lung cancer susceptibility in Asians: a meta-analysis of 18 studies including 7592 cases and 8129 controls. Asian Pac. J. Cancer Prev. V. 12: P. 1067-1072.
  33. Haigis M. C., Yankner B. A. (2010) The aging stress response. Mol. Cell. V. 40: P. 333-344.
  34. Han J., Colditz G. A., Liu J. S., Hunter D. J. (2005) Genetic variation in XPD, sun exposure, and risk of skin cancer. Cancer Epidemiol. Biomarkers Prev. V. 14: P. 1539-1544.
  35. Han J., Hankinson S. E., De Vivo I., et al. (2003) A prospective study of XRCC1 haplotypes and their interaction with plasma carotenoids on breast cancer risk. Cancer Res. V. 63: P. 8536-8541.
  36. Hansen R. D., Sørensen M., Tjønneland A., et al. (2007) XPA A23G, XPC Lys939Gln, XPD Lys 751Gln and XPD Asp 312Asn polymorphisms, interactions with smoking, alcohol and dietary factors, and risk of colorectal cancer. Mutat. Res. V. 619: P. 68-80.
  37. Hazra T. K., Das A., Das S., et al. (2007) Oxidative DNA damage repair in mammalian cells: a new perspective. DNA Repair (Amst). V. 6: P. 470-480.
  38. Hoeijmakers J. H. J. (1995) Nucleotide excision repair: molecular and clinical implications. DNA Repair Mechanisms: Impact on Human Diseases and Cancer/Ed. Jean-Michel H. Vos. N. Y., Berlin, Heidelberg, Paris: Springer-Verlag. P. 126-150.
  39. Hou S. M., Fält S., Angelini S., et al. (2002) The XPD variant alleles are associated with increased aromatic DNA adduct level and lung cancer risk. Carcinogenesis. V. 23: P. 599-603.
  40. Hu Z., Ma H., Chen F., et al. (2005) XRCC1 polymorphisms and cancer risk: a meta-analysis of 38 case-control studies. Cancer Epidemiol. Biomarkers Prev. V. 14: P. 1810-1818.
  41. Huang M., Dinney C. P., Lin X., et al. (2007) High-order interactions among genetic variants in DNA base excision repair pathway genes and smoking in bladder cancer susceptibility. Cancer Epidemiol. Biomarkers Prev. V. 16: P. 84-91.
  42. Huang W. Y., Berndt S. I., Kang D., et al. (2006) Nucleotide excision repair gene polymorphisms and risk of advanced colorectal adenoma: XPC polymorphisms modify smoking-related risk. Cancer Epidemiol. Biomarkers Prev. V. 15: P. 306-311.
  43. Hung R. J., Brennan P., Canzian F., et al. (2005) Large-scale investigation of base excision repair genetic polymorphisms and lung cancer risk in a multicenter study. J. Natl. Cancer Inst. V. 97: P. 567-576.
  44. Ito H., Hamajima N., Takezaki T., et al. (2002) A limited association of OGG1 Ser326Cys polymorphism for adenocarcinoma of the lung. J. Epidemiol. V. 12: P. 258-265.
  45. Ito H., Matsuo K., Hamajima N., et al. (2004) Gene-environment interactions between the smoking habit and polymorphisms in the DNA repair genes, APE1 Asp148Glu and XRCC1 Arg399Gln, in Japanese lung cancer risk. Carcinogenesis. V. 25: P. 1395-1401.
  46. Janković S., Radosavljević V. (2007) Risk factors for bladder cancer. Tumori. V. 93: P. 4-12.
  47. Ji C., Liu Z., Chen H., et al. (2012) An association between hOGG1 Ser326Cys polymorphism and the risk of bladder cancer in non-smokers: a meta-analysis. BMC Cancer. V. 12: 335.
  48. Ji Y. B., Tae K., Lee Y. S., et al. (2010) XPD polymorphisms and risk of squamous cell carcinoma of the head and neck in a Korean sample. Clin. Exp. Otorhinolaryngol. V. 3: P. 42-47.
  49. Jiao L., Hassan M. M., Bondy M. L., et al. (2007) The XPD Asp 312Asn and Lys 751Gln polymorphisms, corresponding haplotype, and pancreatic cancer risk. Cancer Lett. V. 245: P. 61-68.
  50. Justenhoven C., Hamann U., Pesch B., et al. (2004) ERCC2 genotypes and a corresponding haplotype are linked with breast cancer risk in a German population. Cancer Epidemiol. Biomarkers Prev. V. 13: P. 2059-2064.
  51. Karahalil B., Emerce E., Koçer B., et al. (2008) The association of OGG1 Ser326Cys polymorphism and urinary 8-OHdG levels with lung cancer susceptibility: a hospital-based case-control study in Turkey. Arh. Hig. Rada Toksikol. V. 59: P. 241-250.
  52. Kim E. J., Jeong P., Quan C., et al. (2005) Genotypes of TNF-alpha, VEGF, hOGG1, GSTM1, and GSTT1: useful determinants for clinical outcome of bladder cancer. Urology. V. 65: P. 70-75.
  53. Kim S. U., Park S. K., Yoo K. Y., et al. (2002) XRCC1 genetic polymorphism and breast cancer risk. Pharmacogenetics. V. 12: P. 335-338.
  54. Kohno T., Kunitoh H., Toyama K., et al. (2006) Association of the OGG1-Ser326Cys polymorphism with lung adenocarcinoma risk. Cancer Sci. V. 97: P. 724-728.
  55. Kohno T., Shinmura K., Tosaka M. et al. (1998) Genetic polymorphisms and alternative splicing of hOGG1 gene, that is involved in repair of 8-hydroxyguanine in damaged DNA. Oncogene. V. 16. P. 3219-3225.
  56. Lainé J. P., Mocquet V., Bonfanti M., et al. (2007) Common XPD (ERCC2) polymorphisms have no measurable effect on nucleotide excision repair and basal transcription. DNA Repair (Amst). V. 6: P. 1264-1270.
  57. Lan Q., Mumford J. L., Shen M., et al. (2004) Oxidative damage-related genes AKR1C3 and OGG1 modulate risks for lung cancer due to exposure to PAH-rich coal combustion emissions. Carcinogenesis. V. 25: P. 2177-2181.
  58. Lavender N. A., Komolafe O. O., Benford M., et al. (2010) No association between variant DNA repair genes and prostate cancer risk among men of African descent. Prostate. V. 70: P. 113-119.
  59. Le Marchand L., Donlon T., Lum-Jones A., et al. (2002) Association of the hOGG1 Ser326Cys polymorphism with lung cancer risk. Cancer Epidemiol. Biomarkers Prev. V. 11: P. 409-412.
  60. Lee J. M., Lee Y. C., Yang S. Y., et al. (2001) Genetic polymorphisms of XRCC1 and risk of the esophageal cancer. Int. J. Cancer. V. 95: P. 240-246.
  61. Li C., Hu Z., Liu Z., et al. (2006) Polymorphisms in the DNA repair genes XPC, XPD, and XPG and risk of cutaneous melanoma: a case-control analysis. Cancer Epidemiol. Biomarkers Prev. V. 15: P. 2526-2532.
  62. Liang G., Xing D., Miao X., et al. (2003) Sequence variations in the DNA repair gene XPD and risk of lung cancer in a Chinese population. Int. J. Cancer. V. 105: P. 669-673.
  63. Lόpez-Cima M. F., González-Arriaga P., García-Casto L., et al. (2007) Polymorphisms in XPC, XPD, XRCC1, and XRCC3 DNA repair genes and lung cancer risk in a population of northern Spain. BMC Cancer. V. 7: 162.
  64. Lovatt T., Alldersea J., Lear J. T., et al. (2005) Polymorphism in the nuclear excision repair gene ERCC2/XPD: association between an exon 6-exon 10 haplotype and susceptibility to cutaneous basal cell carcinoma. Hum. Mutat. V. 25: P. 353-359.
  65. Matullo G., Dunning A. M., Guarrera S., et al. (2006) DNA repair polymorphisms and cancer risk in non-smokers in a cohort study. Carcinogenesis. V. 27: P. 997-1007.
  66. Mechanic L. E., Millikan R. C., Player J., et al. (2006)Polymorphisms in nucleotide excision repair genes, smoking and breast cancer in African Americans and whites: a population-based case-control study. Carcinogenesis. V. 27: P. 1377-1385.
  67. Metsola K., Kataja V., Sillanpää P., et al. (2005) XRCC1 and XPD genetic polymorphisms, smoking and breast cancer risk in a Finnish case-control study. Breast Cancer Res. V. 7: P. 987-997.
  68. Misra R. R., Ratnasinghe D., Tangrea J. A., et al. (2003) Polymorphisms in the DNA repair genes XPD, XRCC1, XRCC3, and APE/ref-1, and the risk of lung cancer among male smokers in Finland. Cancer Letters. V. 191: P. 171-178.
  69. Mittal R. D., Mandal R. K., Gangwar R. (2012) Base excision repair pathway genes polymorphism in prostate and bladder cancer risk in North Indian population. Mech. Ageing Dev. V. 133: P. 127-132.
  70. Miyaishi A., Osawa K., Osawa Y., et al. (2009) MUTYH Gln324His gene polymorphism and genetic susceptibility for lung cancer in a Japanese population. J. Exp. Clin. Cancer Res. V. 28: 10.
  71. Moreno V., Martín M. L., Bosch F. X., et al. (1996) Combined analysis of matched and unmatched case-control studies: comparison of risk estimates from different studies. Am. J. Epidemiol. V. 143: P. 293-300.
  72. Moullan N., Cox D. G., Angèle S., et al. (2003) Polymorphisms in the DNA repair gene XRCC1, breast cancer risk, and response to radiotherapy. Cancer Epidemiol. Biomarkers Prev. V. 12: P. 1168-1174.
  73. Narter K. F., Ergen A., Agaçhan B., et al. (2009) Bladder cancer and polymorphisms of DNA repair genes (XRCC1, XRCC3, XPD, XPG, APE1, hOGG1). Anticancer Res. V. 29: P. 1389-1393.
  74. Nelson H. H., Kelsey K. T., Mott L. A., Karagas M. R. (2002) The XRCC1 Arg 399Gln polymorphism, sunburn, and non-melanoma skin cancer: evidence of gene-environment interaction. Cancer Res. V. 62: P. 152-155.
  75. Nock N. L., Cicek M. S., Li L., et al. (2006) Polymorphisms in estrogen bioactivation, detoxification and oxidative DNA base excision repair genes and prostate cancer risk. Carcinogenesis. V. 27: P. 1842-1848.
  76. Okasaka T., Matsuo K., Suzuki T., et al. (2009) hOGG1 Ser326Cys polymorphism and risk of lung cancer by histological type. J. Hum. Genet. V. 54: P. 739-745.
  77. Pakakasama S., Sirirat T., Kanchanachumpol S., et al. (2007) Genetic polymorphisms and haplotypes of DNA repair genes in childhood acute lymphoblastic leukemia. Pediatr. Blood Cancer. V. 48: P. 16-20.
  78. Park J., Chen L., Tockman M. S., et al. (2004) The human 8-oxoguanine DNA N-glycosylase 1 (hOGG1) DNA repair enzyme and its association with lung cancer risk. Pharmacogenetics. V. 14: P. 103-109.
  79. Park J. Y., Lee S. Y., Jeon H. S., et al. (2002) Polymorphism of the DNA repair gene XRCC1 and risk of primary lung cancer. Cancer Epidemiol. Biomarkers Prev. V. 11: P. 23-27.
  80. Peltomäki P. (2001) Deficient DNA mismatch repair: a common etiologic factor for colon cancer. Hum. Mol. Genet. V. 10: P. 735-740.
  81. Qian B., Zhang H., Zhang L., et al. (2011) Association of genetic polymorphisms in DNA repair pathway genes with non-small cell lung cancer risk. Lung Cancer. V. 73: P. 138-146.
  82. Sambrook J., Fritsch E. F., Maniatis T. (1989) Isolation of high-molecular-weight DNA from mammalian cells. Molecular Cloning: A Laboratory Manual. 2nd ed., Plainview, N. Y.: Cold Spring Harbor Laboratory Press. P. 9.14-9.23.
  83. Sanyal S., Festa F., Sakano S., et al. (2004) Polymorphisms in DNA repair and metabolic genes in bladder cancer. Carcinogenesis. V. 25: P. 729-734.
  84. Savina N. V., Smal M. P., Kuzhir T. D., et al. (2012)DNA-damage response associated with occupational exposure, age and chronic inflammation in workers in the automotive industry. Mutat. Res. V. 748: P. 21-28.
  85. Schabath M. B., Delclos G. L., Grossman H. B., et al. (2005) Polymorphisms in XPD exons 10 and 23 and bladder cancer risk. Cancer Epidemiol. Biomarkers Prev. V. 14: P. 878-884.
  86. Settheetham-Ishida W., Yuenyao P., Natphopsuk S., et al. (2011) Genetic risk of DNA repair gene polymorphisms (XRCC1 and XRCC3) for high risk human papillomavirus negative cervical cancer in Northeast Thailand. Asian Pac. J. Cancer Prev. V. 12: P. 963-966.
  87. Shen M. R., Jones I. M., Mohrenweiser H. (1998) Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans. Cancer Res. V. 58: P. 604-608.
  88. Shu X. O., Cai Q., Gao Y. T., et al. (2003) A population-based case-control study of the Arg 399Gln polymorphism in DNA repair gene XRCC1 and risk of breast cancer. Cancer Epidemiol. Biomarkers Prev. V. 12: P. 1462-1467.
  89. Smith T. R., Levine E. A., Perrier N. D., et al. (2003) DNA-repair genetic polymorphisms and breast cancer risk. Cancer Epidemiol. Biomarkers Prev. V. 12: P. 1200-1204.
  90. Sørensen M., Raaschou-Nielsen O., Hansen R. D., et al. (2006) Interactions between the OGG1 Ser326Cys polymorphism and intake of fruit and vegetables in relation to lung cancer. Free Radic. Res. V. 40. P. 885-891.
  91. Sugimura H., Kohno T., Wakai K., et al. (1999) hOGG1 Ser326Cys polymorphism and lung cancer susceptibility. Cancer Epidemiol. Biomarkers Prev. V. 8: P. 669-674.
  92. Teebor G. W., 1995. Excision base repair. DNA Repair Mechanisms: Impact on Human Diseases and Cancer/Ed. Jean-Michel H. Vos. N. Y., Berlin, Heidelberg, Paris: Springer Verlag. P. 99-123.
  93. Tudek B. (2007) Base excision repair modulation as a risk factor for human cancers. Mol. Aspects Med. V. 28: P. 258-275.
  94. Turner N., Tutt A., Ashworth A. (2005) Targeting the DNA repair defect of BRCA tumours. Curr. Opin. Farmacol. V. 5: P. 388-393.
  95. Tutt A., Ashworth A. (2002) The relationship between the roles of BRCA genes in DNA repair and cancer predisposition. Trends Mol. Med. V. 8: P. 571-576.
  96. Vodicka P., Stetina R., Polakova V., et al. (2007) Association of DNA repair polymorphisms with DNA repair functional outcomes in healthy human subjects. Carcinogenesis. V. 28: P. 657-664.
  97. Wang F., Chang D., Hu F. L., et al. (2008) DNA repair gene XPD polymorphisms and cancer risk: a meta-analysis based on 56 case-control studies. Cancer Epidemiol. Biomarkers Prev. V. 17: P. 507-517.
  98. Wang W., Wu Y. J., Wu Y. M. (2005) Genetic polymorphism in hOGG1 and susceptibility to lung cancer. Carcinogenesis, Teratogenesis & Mutagenesis. V. 17: P. 101-103.
  99. Wei B., Zhou Y., Xu Z., et al. (2011) The effect of hOGG1 Ser326Cys polymorphism on cancer risk: evidence from a meta-analysis. PLoS One. V. 6: e27545. doi: 10.1371/journal.pone.0027545.
  100. Weiss J. M., Goode E. L., Ladiges W. C., Ulrich C. M. (2005 a) Polymorphic variation in hOGG1 and risk of cancer: a review of the functional and epidemiologic literature. Mol. Carcinog. V. 42: P. 127-141.
  101. Weiss J. M., Weiss N. S., Ulrich C. M., et al. (2005 b) Interindividual variation in nucleotide excision repair genes and risk of endometrial cancer. Cancer Epidemiol. Biomarkers Prev. V. 14: P. 2524-2530.
  102. Wikman H., Risch A., Klimek F., et al. (2000) hOGG1 polymorphism and loss of heterozygosity (LOH): significance for lung cancer susceptibility in a caucasian population. Int. J. Cancer. V. 88: P. 932-937.
  103. Wu X., Gu J., Grossman H. B., et al. (2006) Bladder cancer predisposition: a multigenic approach to DNA-repair and cell-cycle-control genes. Am. J. Hum. Genet. V. 78: P. 464-479.
  104. Xing D., Qi J., Miao X., et al. (2002) Polymorphisms of DNA repair genes XRCC1 and XPD and their associations with risk of esophageal squamous cell carcinoma in a Chinese population. Int. J. Cancer. Vol. 100: P. 600-605.
  105. Yamane A., Kohno T., Ito K., et al. (2004) Differential ability of polymorphic OGG1 proteins to suppress mutagenesis induced by 8-hydroxyguanine in human cell in vivo. Carcinogenesis. V. 25: P. 1689-1694.
  106. Ye W., Kumar R., Bacova G., et al. (2006) The XPD 751Gln allele is associated with an increased risk for esophageal adenocarcinoma: a population-based case-control study in Sweden. Carcinogenesis. V. 27: P. 1835-1841.
  107. Yu H. P., Wang X. L., Sun X., et al. (2004) Polymorphisms in the DNA repair gene XPD and susceptibility to esophageal squamous cell carcinoma. Cancer Genet. Cytogenet. V. 154: P. 10-15.
  108. Yu M. W., Yang S. Y., Pan I. J., et al. (2003) Polymorphisms in XRCC1 and glutathione S-transferase genes and hepatitis B-related hepatocellular carcinoma. J. Natl. Cancer Inst. V. 95: P. 1485-1488.
  109. Yun S. J., Ha Y. S., Chae Y., et al. (2012) The hOGG1 mutant genotype is associated with prostate cancer susceptibility and aggressive clinicopathological characteristics in the Korean population. Ann. Oncol. V. 23: P. 401-405.
  110. Zhang J., Dhakal I. B., Greene G., et al. (2010) Polymorphisms in hOGG1 and XRCC1 and risk of prostate cancer: effects modified by plasma antioxidants. Urology. V. 75: P. 779-785.
  111. Zhang X., Miao X., Liang G., et al. (2005) Polymorphisms in DNA base excision repair genes ADPRT and XRCC1 and risk of lung cancer. Cancer Res. V. 65: P. 722-726.
  112. Zhong D., Li G., Long J., et al. (2012 a) The hOGG1 Ser326Cys polymorphism and increased lung cancer susceptibility in Caucasians: an updated meta-analysis. Sci. Rep. V. 2: 548. doi: 10.1038/srep00548.
  113. Zhong D. Y., Chu H. Y., Wang M. L., et al. (2012 b)Meta-analysis demonstrates lack of association of the hOGG1 Ser326Cys polymorphism with bladder cancer risk. Genet. Mol. Res. V. 11: P. 3490-3496.
  114. Zhou W., Liu G., Miller D. P., et al. (2002) Gene-environment interaction for the ERCC2 polymorphisms and cumulative cigarette smoking exposure in lung cancer. Cancer Res. V. 62: P. 1377-1381.
  115. Zhou W., Liu G., Miller D. P., et al. (2003) Polymorphisms in the DNA repair genes XRCC1 and ERCC2, smoking, and lung cancer risk. Cancer Epidemiol. Biomarkers Prev. V. 12: P. 359-365.

Copyright (c) 2013 Ramaniuk V.P., Nikitchenko N.V., Savina N.V., Kuzhir T.D., Goncharova R.I.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies